Tackling acute myeloid leukemia via diverse pathways
Tackling acute myeloid leukemia via diverse path
Tackling acute myeloid leukemia via diverse path
New options in untreated and pretreated mantle c
Prolonging remission in relapsed and refractory
BTK inhibition in Waldenström’s macroglobulinemi
Early-phase trials investigating novel agents in
Marginal zone lymphoma: benefits of BTK inhibiti
Updates and ancillary analyses in the setting of
Preface – EHA 2022 Matthew S. Davids, M